Intervention Based on the Dietary Guidelines for the Brazilian Population for the Treatment of Overweight and Obesity

April 15, 2026 updated by: Profª Drª Fernanda Michielin Busnello, Federal University of Health Science of Porto Alegre

Efficacy of an Intervention Based on the Dietary Guidelines for the Brazilian Population in the Treatment of Overweight and Obesity: A Randomized Clinical Trial

This clinical trial aims to evaluate how group-based food and nutrition education interventions, grounded in the recommendations of the Dietary Guidelines for the Brazilian Population, can improve participants' dietary quality and support the treatment of overweight and obesity.

The study seeks to determine whether individuals with overweight and obesity receiving outpatient care who participate in collective food and nutrition education activities achieve benefits similar to those receiving individual nutritional counseling, particularly improvements in dietary intake, clinical parameters, and anthropometric measures.

Participants will be divided into two groups and will be required to attend four monthly sessions, complete questionnaires before and after the sessions, and provide consent for the collection of data from their medical records.

Researchers will compare the outcomes of participants attending group sessions with those receiving individual care to assess whether collective actions provide similar benefits in improving dietary quality, blood test results, and anthropometric measures.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil, 90050170
        • Federal University of Health Sciences of Porto Alegre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults (≥18 years of age)
  • Individuals of both biological sexes
  • Body Mass Index (BMI) ≥ 25 kg/m²

Exclusion Criteria:

  • Pregnant or lactating women
  • Cognitive, neurological, or psychiatric disorders that interfere with study compliance or participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Individual Care Control Group
The control group will receive individualized nutritional counseling comprising four in-person consultations over a 4-month period.
The control group will receive individualized nutritional counseling consisting of four in-person consultations, conducted once monthly over a four-month period. Each session, lasting 50-60 minutes, will be led by a nutritionist. These consultations will focus on establishing goals for dietary habit modification and on developing a personalized nutritional plan to improve overall dietary quality.
Experimental: Collective Intervention Group based on the Dietary Guidelines for the Brazilian Population
Participants will attend four monthly collective Food and Nutrition Education sessions.
Participants in the intervention group will attend four monthly in-person Food and Nutrition Education sessions based on the Dietary Guidelines for the Brazilian Population. These sessions will facilitate discussions on healthy eating and incorporate activities designed to dispel nutritional myths. The curriculum will address the NOVA classification system, critical appraisal of food labels, and making informed food choices. Additionally, a culinary workshop will feature healthy, affordable recipes. This component aims to enhance culinary skills, broaden dietary repertoire, and ultimately reduce the consumption of ultra-processed foods.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dietary Assessment
Time Frame: Before and After the 4-Month Interventions
Dietary intake will be assessed using the 24-hour dietary recall available on the Quest Nova platform. This instrument consists of 58 items featuring common foods in the Brazilian diet; participants indicate the consumption of each item via dichotomous (yes/no) responses. The estimated completion time for the questionnaire is 15 minutes. This tool enables the identification of both quantitative and qualitative aspects of the participants' dietary habits. To ensure a representative average of intake, the assessment will be administered twice within the same week, both at baseline (pre-intervention) and post-intervention.
Before and After the 4-Month Interventions
Dietary Practice Scale of the Dietary Guidelines for the Brazilian Population
Time Frame: Before and After the 4-Month Interventions
Adherence to healthy eating practices will be measured using the Dietary Practice Scale based on the Dietary Guidelines for the Brazilian Population. This validated, self-administered instrument consists of 24 statements regarding healthy dietary habits as recommended by the guidelines. For each statement, participants indicate their level of adherence using a 4-point Likert scale ranging from "Strongly Agree" to "Strongly Disagree." The scale is a robust tool designed to quantify compliance with national dietary recommendations and to evaluate the overall quality of food-related behaviors.
Before and After the 4-Month Interventions

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI)
Time Frame: Before and after the 4-month interventions
BMI will be calculated as weight (kg) divided by height squared (m²).
Before and after the 4-month interventions
Waist circumference
Time Frame: Before and after the 4-month interventions
Waist circumference will be measured using a non-elastic measuring tape at standardized anatomical landmarks. Measurements will be taken three times, and the mean value will be used. Unit of Measure is centimeters (cm).
Before and after the 4-month interventions
Fasting blood glucose
Time Frame: Before and after the 4-month interventions
The data will be collected from medical records. The unit of measurement used will be mg/dL.
Before and after the 4-month interventions
Glycated hemoglobin (HbA1c)
Time Frame: Before and After the 4-Month Interventions
Medical records will be used to gather data. Unit of Measure will be %
Before and After the 4-Month Interventions
Total cholesterol
Time Frame: Before and After the 4-Month Interventions
Data will be gathered from medical records. Unit of Measure will be mg/dL
Before and After the 4-Month Interventions
HDL cholesterol
Time Frame: Before and After the 4-Month Interventions
Data will be collected from medical records. Unit of Measure will be mg/dL
Before and After the 4-Month Interventions
LDL cholesterol
Time Frame: Before and After the 4-Month Interventions
Data will be collected from medical records. Unit of Measure will be mg/dL
Before and After the 4-Month Interventions
Triglycerides
Time Frame: Before and After the 4-Month Interventions
Data will be collected from medical records. Unit of Measure will be mg/dL
Before and After the 4-Month Interventions
C-reactive protein
Time Frame: Before and After the 4-Month Interventions
Data will be collected from medical records. Unit of Measure will be mg/L
Before and After the 4-Month Interventions
Uric acid
Time Frame: Before and After the 4-Month Interventions
Data will be collected from medical records. Unit of Measure will be mg/L
Before and After the 4-Month Interventions
Transtheoretical Model of Change
Time Frame: Before and after the 4-month interventions
Stage of behavior change will be assessed using the Transtheoretical Model (Prochaska Scale), in which participants will be classified into one of five stages (pre-contemplation, contemplation, preparation, action, or maintenance) based on their readiness to engage in weight management behaviors, and the outcome will be analyzed as a categorical variable representing the participant's stage of change (5 levels).
Before and after the 4-month interventions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

March 31, 2026

First Submitted That Met QC Criteria

April 15, 2026

First Posted (Actual)

April 20, 2026

Study Record Updates

Last Update Posted (Actual)

April 20, 2026

Last Update Submitted That Met QC Criteria

April 15, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to the sensitive nature of the clinical data and the absence of a data-sharing clause in the Informed Consent Form, these records will not be made publicly available. Access will be strictly limited to the primary investigators.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity & Overweight

Clinical Trials on Control Group: Individualized Care

Subscribe